VCRIX
Price
$14.52
Change
-$0.13 (-0.89%)
Updated
Sep 16 closing price
Net Assets
1.34B
VCRVX
Price
$14.50
Change
-$0.12 (-0.82%)
Updated
Sep 16 closing price
Net Assets
N/A
Interact to see
Advertisement

VCRIX vs VCRVX

Header iconVCRIX vs VCRVX Comparison
Open Charts VCRIX vs VCRVXBanner chart's image
NYLI CBRE Global Infrastructure
Price$14.52
Change-$0.13 (-0.89%)
VolumeN/A
Net Assets1.34B
NYLI CBRE Global Infrastructure Inv Cl
Price$14.50
Change-$0.12 (-0.82%)
VolumeN/A
Net AssetsN/A
VCRIX vs VCRVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VCRIX vs. VCRVX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VCRIX is a StrongBuy and VCRVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCRIX pays higher dividends than VCRVX: VCRIX (2.03) vs VCRVX (1.70). VCRIX was incepted earlier than VCRVX: VCRIX (12 years) vs VCRVX (6 years). VCRVX (1.35) is less costly to investors than VCRIX (1.03). VCRIX (81.00) and VCRVX (81.00) have comparable annual turnover. VCRVX has a lower initial minimum investment than VCRIX: VCRVX (1000) vs VCRIX (1000000). VCRIX (7.33) and VCRVX (7.04) have marching annual gain over last year. VCRIX return over 5 years is better than : 44.37 vs. VCRVX (42.20).
VCRIXVCRVXVCRIX / VCRVX
Total Expense Ratio0.971.3572%
Annual Report Gross Expense Ratio1.031.3576%
Fund Existence12 years6 years-
Gain YTD12.52512.363101%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.34BN/A-
Annual Yield % from dividends2.031.70119%
Returns for 1 year7.337.04104%
Returns for 3 years22.9221.72106%
Returns for 5 years44.3742.20105%
Returns for 10 years66.85N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRLT2.380.02
+0.85%
Brilliant Earth Group
PLD114.030.77
+0.68%
PROLOGIS
CADL4.85N/A
N/A
Candel Therapeutics
DMLP25.39-0.04
-0.16%
Dorchester Minerals LP
AXSM114.10-2.68
-2.29%
Axsome Therapeutics